January 2026
1. SKJOTH JB, Nielsen H, Orskov M, Cehofski L, et al
   Diabetic retinopathy in Greenland and Denmark-Can differences in risk factors explain the lower prevalence in Greenland?
   Acta Ophthalmol. 2026 Jan 28. doi: 10.1111/aos.70064.
   

   >> Share

   
   September 2025
2. POSCHKAMP B, Kantz L, Augstein P, Tayar A, et al
   Customizing AI-based screening with real-world data: Practical insights from diabetic retinopathy.
   Acta Ophthalmol. 2025 Sep 11. doi: 10.1111/aos.17591.
   

   >> Share

   
   
3. AMINI A, Hamann S, Larsen M
   Semaglutide and non-arteritic anterior ischaemic optic neuropathy: Review and interpretation of reported association.
   Acta Ophthalmol. 2025;103:615-621.
   

   >> Share

   
   
4. ABU ISHKHEIDEM I, Breimer M, Kamal S, Zetterberg M, et al
   Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: A retrospective Swedish cohort study.
   Acta Ophthalmol. 2025;103:699-706.
   

   >> Share

   
   June 2025
5. HUHTINEN P, Kubin AM, Piila L, Hautala N, et al
   Performance and accuracy of 10 AI-based algorithms in diabetic retinopathy screening in a real-world clinical setting.
   Acta Ophthalmol. 2025 Jun 27. doi: 10.1111/aos.17542.
   

   >> Share

   
   
6. SABAL B, Wylegala E, Teper S
   Response to subthreshold micropulse laser treatment in the prophylaxis of diabetic macular oedema: A preliminary study.
   Acta Ophthalmol. 2025 Jun 27. doi: 10.1111/aos.17548.
   

   >> Share

   
   April 2025
7. VIGGIANO P, Santoro M, Boscia G, Porreca A, et al
   Impact of diabetes and diabetic retinopathy on neovascular exudative age-related macular degeneration.
   Acta Ophthalmol. 2025 Apr 17. doi: 10.1111/aos.17502.
   

   >> Share

   
   March 2025
8. BORRAS-BLASCO J, Abad J, Cornejo-Uixeda S, Perez Gil L, et al
   Economic impact of a faricimab vial-sharing protocol in age-related macular degeneration and diabetic macular oedema patients.
   Acta Ophthalmol. 2025 Mar 12. doi: 10.1111/aos.17483.
   

   >> Share

   
   January 2025
9. ABU EL-ASRAR AM, Alsarhani WK, AlBloushi AF, Alzubaidi A, et al
   Effect of panretinal photocoagulation on retinal oxygen metabolism and ocular blood flow in diabetic retinopathy.
   Acta Ophthalmol. 2025 Jan 30. doi: 10.1111/aos.17442.
   

   >> Share

   
   December 2024
10. GRZYBOWSKI A, Peeters F, Barao RC, Brona P, et al
    Evaluating the efficacy of AI systems in diabetic retinopathy detection: A comparative analysis of Mona DR and IDx-DR.
    Acta Ophthalmol. 2024 Dec 10. doi: 10.1111/aos.17428.
    

    >> Share

    
    October 2024
11. SIMILIE DE, Andersen JKH, Dinesen S, Savarimuthu TR, et al
    Grading of diabetic retinopathy using a pre-segmenting deep learning classification model: Validation of an automated algorithm.
    Acta Ophthalmol. 2024 Oct 19. doi: 10.1111/aos.16781.
    

    >> Share

    
    June 2024
12. RESTE-FERREIRA D, Marques IP, Santos T, Ribeiro ML, et al
    Retinal neurodegeneration in eyes with NPDR risk phenotypes: A two-year longitudinal study.
    Acta Ophthalmol. 2024;102:e539-e547.
    

    >> Share

    
    May 2024
13. STOKHOLM L, Pedersen FN, Andersen N, Andresen J, et al
    Presence and development of diabetic retinopathy in 16 999 patients with type 1 diabetes in the Danish Registry of Diabetic Retinopathy.
    Acta Ophthalmol. 2024 May 18. doi: 10.1111/aos.16707.
    

    >> Share

    
    
14. HATAMNEJAD A, Orr S, Dadak R, Khanani A, et al
    Anti-VEGF and steroid combination therapy relative to anti-VEGF mono therapy for the treatment of refractory DME: A systematic review of efficacy and meta-analysis of safety.
    Acta Ophthalmol. 2024;102:e204-e214.
    

    >> Share

    
    April 2024
15. SU ZZS, Ang BCH, Balne PK, Tun SBB, et al
    Effect of anti-VEGF on retinal blood flow in diabetic mice using laser speckle flowgraphy.
    Acta Ophthalmol. 2024 Apr 4. doi: 10.1111/aos.16672.
    

    >> Share

    
    March 2024
16. LINDBOE JB, Brynskov T, Sorensen TL, Schmidt Laugesen C, et al
    Real-world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008-2021.
    Acta Ophthalmol. 2024 Mar 25. doi: 10.1111/aos.16677.
    

    >> Share

    
    
17. HELOTERA H, Arffman M, Sund R, Keskimaki I, et al
    The incidence and prevalence of diabetic macular edema and proliferative diabetic retinopathy, their progression to visual impairment and patterns in their intravitreal treatment in the Finnish population.
    Acta Ophthalmol. 2024 Mar 24. doi: 10.1111/aos.16675.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share